Literature DB >> 33776901

Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice.

Jiuyang Chang1, Masahiro Koseki1, Ayami Saga1, Kotaro Kanno1, Tomoaki Higo1, Daisuke Okuzaki2, Takeshi Okada1, Hiroyasu Inui1, Katsunao Tanaka1, Masumi Asaji1, Yinghong Zhu1, Yoshihiro Kamada3, Masafumi Ono4, Toshiji Saibara5, Ikuyo Ichi6, Tohru Ohama1, Makoto Nishida7, Shizuya Yamashita8, Yasushi Sakata1.   

Abstract

Non-alcoholic fatty liver disease is strongly associated with obese and type 2 diabetes. It has been reported that an oxidized cholesterol, 7-ketocholesterol (7KC), might cause inflammatory response in macrophages and plasma 7KC concentration were higher in patients with cardiovascular diseases or diabetes. Therefore, we have decided to test whether small amount of 7KC in diet might induce hepatic steatosis and inflammation in two types of obese models. We found that addition of 0.01% 7KC either in chow diet (CD, regular chow diet with 1% cholesterol) or western type diet (WD, high fat diet with 1% cholesterol) accelerated hepatic neutral lipid accumulation by Oil Red O staining. Importantly, by lipid extraction analysis, it has been recognized that triglyceride rather than cholesterol species was significantly accumulated in CD+7KC compared to CD as well as in WD+7KC compared to WD. Immunostaining revealed that macrophages infiltration was increased in CD+7KC compared to CD, and also in WD+7KC compared to WD. These phenotypes were accompanied by inducing inflammatory response and downregulating fatty acid oxidation. Furthermore, RNA sequence analysis demonstrated that 7KC reduced expression of genes which related to autophagy process. Levels of LC3-II protein were decreased in WD+7KC compared to WD. Similarly, we have confirmed the effect of 7KC on acceleration of steatohepatitis in db/db mice model. Collectively, our study has demonstrated that small amount of dietary 7KC contributed to accelerate hepatic steatosis and inflammation in obese mice models.
Copyright © 2021 Chang, Koseki, Saga, Kanno, Higo, Okuzaki, Okada, Inui, Tanaka, Asaji, Zhu, Kamada, Ono, Saibara, Ichi, Ohama, Nishida, Yamashita and Sakata.

Entities:  

Keywords:  7-ketocholesterol; autophagy; macrophage; obesity; steatohepatitis

Mesh:

Substances:

Year:  2021        PMID: 33776901      PMCID: PMC7989701          DOI: 10.3389/fendo.2020.614692

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  44 in total

1.  Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.

Authors:  Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Stefano Rodella; Roberto Tessari; Luciano Zenari; Christopher Day; Guido Arcaro
Journal:  Diabetes Care       Date:  2007-02-02       Impact factor: 19.112

2.  CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure.

Authors:  Xiaoquan Rao; Jixin Zhong; Andrei Maiseyeu; Bhavani Gopalakrishnan; Frederick A Villamena; Lung-Chi Chen; Jack R Harkema; Qinghua Sun; Sanjay Rajagopalan
Journal:  Circ Res       Date:  2014-09-03       Impact factor: 17.367

3.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

4.  Oxysterol species: reliable markers of oxidative stress in diabetes mellitus.

Authors:  A Samadi; A Gurlek; S N Sendur; S Karahan; F Akbiyik; I Lay
Journal:  J Endocrinol Invest       Date:  2018-03-21       Impact factor: 4.256

5.  Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Authors:  Victor W Zhong; Linda Van Horn; Marilyn C Cornelis; John T Wilkins; Hongyan Ning; Mercedes R Carnethon; Philip Greenland; Robert J Mentz; Katherine L Tucker; Lihui Zhao; Arnita F Norwood; Donald M Lloyd-Jones; Norrina B Allen
Journal:  JAMA       Date:  2019-03-19       Impact factor: 56.272

6.  A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers.

Authors:  Yoshihiro Kamada; Masafumi Ono; Hideyuki Hyogo; Hideki Fujii; Yoshio Sumida; Kojiroh Mori; Saiyu Tanaka; Makoto Yamada; Maaya Akita; Kayo Mizutani; Hironobu Fujii; Akiko Yamamoto; Shinji Takamatsu; Yuichi Yoshida; Yoshito Itoh; Norifumi Kawada; Kazuaki Chayama; Toshiji Saibara; Tetsuo Takehara; Eiji Miyoshi
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

7.  Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.

Authors:  Takashi Nakahara; Hideyuki Hyogo; Masato Yoneda; Yoshio Sumida; Yuichiro Eguchi; Hideki Fujii; Masafumi Ono; Takumi Kawaguchi; Kento Imajo; Hiroshi Aikata; Saiyu Tanaka; Kazuyuki Kanemasa; Kazuma Fujimoto; Keizo Anzai; Toshiji Saibara; Michio Sata; Atushi Nakajima; Yoshito Itoh; Kazuaki Chayama; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2013-11-26       Impact factor: 7.527

8.  Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.

Authors:  Takahisa Kawaguchi; Yoshio Sumida; Atsushi Umemura; Keitaro Matsuo; Meiko Takahashi; Toshinari Takamura; Kohichiroh Yasui; Toshiji Saibara; Etsuko Hashimoto; Miwa Kawanaka; Sumio Watanabe; Sumio Kawata; Yasuharu Imai; Miki Kokubo; Toshihide Shima; Hyohun Park; Hideo Tanaka; Kazuo Tajima; Ryo Yamada; Fumihiko Matsuda; Takeshi Okanoue
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 9.  7-Ketocholesterol in disease and aging.

Authors:  Amelia Anderson; Angielyn Campo; Elena Fulton; Anne Corwin; W Gray Jerome; Matthew S O'Connor
Journal:  Redox Biol       Date:  2019-11-14       Impact factor: 11.799

10.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

View more
  3 in total

1.  Oxysterols in stored powders as potential health hazards.

Authors:  Sylwia Chudy; Joanna Teichert
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

2.  Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.

Authors:  Kotaro Kanno; Masahiro Koseki; Jiuyang Chang; Ayami Saga; Hiroyasu Inui; Takeshi Okada; Katsunao Tanaka; Masumi Asaji; Yinghong Zhu; Seiko Ide; Shigeyoshi Saito; Tomoaki Higo; Daisuke Okuzaki; Tohru Ohama; Makoto Nishida; Yoshihiro Kamada; Masafumi Ono; Toshiji Saibara; Shizuya Yamashita; Yasushi Sakata
Journal:  Sci Rep       Date:  2022-02-22       Impact factor: 4.379

3.  Dietary 7-ketocholesterol exacerbates myocardial ischemia-reperfusion injury in mice through monocyte/macrophage-mediated inflammation.

Authors:  Tomoki Uchikawa; Tetsuya Matoba; Takuro Kawahara; Isashi Baba; Shunsuke Katsuki; Jun-Ichiro Koga; Yu Hashimoto; Ryo Yamasaki; Ikuyo Ichi; Hidetaka Akita; Hiroyuki Tsutsui
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.